Intellia Therapeutics Inc. (NTLA) at a glance

Intellia Therapeutics Inc. (NTLA) is a Healthcare company. It trades at $13.73. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (33/100).

Price
$13.74
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$7.95 to $28.25
Vestovix Score48/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
33